Autolus Therapeutics Plc (AUTL)
1.70
+0.05
(+3.03%)
USD |
NASDAQ |
May 22, 16:00
1.71
+0.01
(+0.59%)
After-Hours: 20:00
Autolus Therapeutics Cash from Investing (Quarterly) : 95.99M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1037M |
| Mereo BioPharma Group Plc | -0.2995M |
| Bicycle Therapeutics Plc | -0.7118M |
| DBV Technologies SA | -0.3011M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -65.21M |
| Cash from Financing (Quarterly) | -2.058M |
| Free Cash Flow | -295.51M |
| Free Cash Flow Per Share (Quarterly) | -0.2551 |
| Free Cash Flow to Equity (Quarterly) | -85.43M |
| Free Cash Flow to Firm (Quarterly) | -56.65M |
| Free Cash Flow Yield | -65.31% |